Novartis explores expanding direct-to-patient platform ahead of US launch
PositiveFinancial Markets

Novartis is looking to expand its direct-to-patient platform as it prepares for a launch in the US. This move is significant as it reflects the company's commitment to enhancing patient access to its medications, potentially improving health outcomes and patient satisfaction. By leveraging technology to connect directly with patients, Novartis aims to streamline the process of obtaining treatments, making it easier for individuals to manage their health.
— Curated by the World Pulse Now AI Editorial System











